Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false question first answered
creator	label
publisher	pref label
tabling member	label

Search

1142686

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 17:24:14
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 17:25:05 09/09/2019 18:01:05
	hansard heading	Gene Therapies
	house id	1
	identifier	284172
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	09/09/2019 17:29:21
	question text	To ask the Secretary of State for Health and Social Care, what plans NHS England has to implement gene therapy treatments.
	session	2017/19
	session number	1
	tabling member constituency	Wolverhampton South West
	tabling member printed	Eleanor Smith
	title	House of Commons Tabled Parliamentary Question 2017/19 284172
	type	WrittenParliamentaryQuestion
	uin	284172
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 09/09/2019 17:29:21
	creator	4609 label Biography information for Eleanor Smith
	publisher	25259 pref label House of Commons
	tabling member	4609 label Biography information for Eleanor Smith

1142908

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 17:45:40
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 17:55:29 09/09/2019 18:13:03
	hansard heading	Dermatology: General Practitioners
	house id	1
	identifier	284455
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	09/09/2019 17:41:31
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the number of GPs with a special interest in dermatology.
	session	2017/19
	session number	1
	tabling member constituency	Wolverhampton South West
	tabling member printed	Eleanor Smith
	title	House of Commons Tabled Parliamentary Question 2017/19 284455
	type	WrittenParliamentaryQuestion
	uin	284455
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 09/09/2019 17:41:31
	creator	4609 label Biography information for Eleanor Smith
	publisher	25259 pref label House of Commons
	tabling member	4609 label Biography information for Eleanor Smith

1143735

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 18:57:33
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 19:16:54 09/09/2019 18:14:03
	hansard heading	Rare Diseases: Drugs
	house id	1
	identifier	285265
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	09/09/2019 17:42:36
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of the UK leaving the EU without a deal on the regulatory processes for new medicines for rare conditions.
	session	2017/19
	session number	1
	tabling member constituency	Wolverhampton North East
	tabling member printed	Emma Reynolds
	title	House of Commons Tabled Parliamentary Question 2017/19 285265
	type	WrittenParliamentaryQuestion
	uin	285265
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 09/09/2019 17:42:36
	creator	4077 label Biography information for Emma Reynolds
	publisher	25259 pref label House of Commons
	tabling member	4077 label Biography information for Emma Reynolds

1143736

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 18:57:36
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 19:16:57 09/09/2019 18:12:01
	hansard heading	Medicines and Healthcare products Regulatory Agency
	house id	1
	identifier	285266
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	09/09/2019 17:40:45
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the capacity requirements for the Medicines and healthcare products regulatory agency after the UK leaves the EU.
	session	2017/19
	session number	1
	tabling member constituency	Wolverhampton North East
	tabling member printed	Emma Reynolds
	title	House of Commons Tabled Parliamentary Question 2017/19 285266
	type	WrittenParliamentaryQuestion
	uin	285266
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 09/09/2019 17:40:45
	creator	4077 label Biography information for Emma Reynolds
	publisher	25259 pref label House of Commons
	tabling member	4077 label Biography information for Emma Reynolds

1143097

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 18:04:24
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 18:12:41 09/09/2019 18:04:03
	hansard heading	Nutrition: Health Education
	house id	1
	identifier	284770
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	09/09/2019 17:32:42
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to maintain the Eatwell Guide in the event of the UK leaving the EU without a deal.
	session	2017/19
	session number	1
	tabling member constituency	Washington and Sunderland West
	tabling member printed	Mrs Sharon Hodgson
	title	House of Commons Tabled Parliamentary Question 2017/19 284770
	type	WrittenParliamentaryQuestion
	uin	284770
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 09/09/2019 17:32:42
	creator	1521 label Biography information for Mrs Sharon Hodgson
	publisher	25259 pref label House of Commons
	tabling member	1521 label Biography information for Mrs Sharon Hodgson

1143905

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 19:08:11
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	03/09/2019 15:35:41 09/09/2019 18:09:01
	hansard heading	Health Visitors: Recruitment
	house id	1
	identifier	285106
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	09/09/2019 17:37:58
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of trends in health visitor recruitment in (a) the UK, (b) Teesside, and (c) Stockton South constituency.
	session	2017/19
	session number	1
	tabling member constituency	Stockton South
	tabling member printed	Dr Paul Williams
	title	House of Commons Tabled Parliamentary Question 2017/19 285106
	type	WrittenParliamentaryQuestion
	uin	285106
	version	2
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 09/09/2019 17:37:58
	creator	4666 label Biography information for Dr Paul Williams
	publisher	25259 pref label House of Commons
	tabling member	4666 label Biography information for Dr Paul Williams

1143591

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 18:49:46
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	03/09/2019 15:15:28 09/09/2019 18:01:06
	hansard heading	General Practitioners: Standards
	house id	1
	identifier	285030
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	09/09/2019 17:29:05
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy ofwaiting times for GP appointments.
	session	2017/19
	session number	1
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	title	House of Commons Tabled Parliamentary Question 2017/19 285030
	type	WrittenParliamentaryQuestion
	uin	285030
	version	2
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 09/09/2019 17:29:05
	creator	4058 label Biography information for Paul Blomfield
	publisher	25259 pref label House of Commons
	tabling member	4058 label Biography information for Paul Blomfield

1143592

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 18:49:50
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 18:59:44 09/09/2019 18:07:01
	hansard heading	Electronic Cigarettes: Health Education
	house id	1
	identifier	285033
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	09/09/2019 17:35:30
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of NHS guidance on vaping.
	session	2017/19
	session number	1
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	title	House of Commons Tabled Parliamentary Question 2017/19 285033
	type	WrittenParliamentaryQuestion
	uin	285033
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 09/09/2019 17:35:30
	creator	4058 label Biography information for Paul Blomfield
	publisher	25259 pref label House of Commons
	tabling member	4058 label Biography information for Paul Blomfield

1142923

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 17:46:31
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 17:56:10 09/09/2019 18:02:01
	hansard heading	NHS: Drugs
	house id	1
	identifier	284398
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	09/09/2019 17:30:47
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of scrapping Medicines Usage Reviews on people who take multiple medications.
	session	2017/19
	session number	1
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	title	House of Commons Tabled Parliamentary Question 2017/19 284398
	type	WrittenParliamentaryQuestion
	uin	284398
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 09/09/2019 17:30:47
	creator	4126 label Biography information for Mary Glindon
	publisher	25259 pref label House of Commons
	tabling member	4126 label Biography information for Mary Glindon

1143878

	human indexable
	published
	registered interest
	answer date	04/09/2019
	date	02/09/2019
	date tabled	02/09/2019
	ddp created	02/09/2019 19:06:53
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/09/2019 19:22:59 09/09/2019 18:09:03
	hansard heading	5G: Health Hazards
	house id	1
	identifier	285341
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	09/09/2019 17:37:17
	question text	To ask the Secretary of State for Health and Social Care, what research his Department has (a) undertaken and (b) commissioned on the effect of 5G towers on public health.
	session	2017/19
	session number	1
	tabling member constituency	Motherwell and Wishaw
	tabling member printed	Marion Fellows
	title	House of Commons Tabled Parliamentary Question 2017/19 285341
	type	WrittenParliamentaryQuestion
	uin	285341
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 09/09/2019 17:37:17
	creator	4440 label Biography information for Marion Fellows
	publisher	25259 pref label House of Commons
	tabling member	4440 label Biography information for Marion Fellows